Marina Naoi, Ryo Tamura, Masanobu Sato, Ikumi Tamai, Yoshiyuki Shirasaka. Impact of Membrane Permeability of P-glycoprotein Inhibitors on the Risk Assessment of Intestinal P-glycoprotein-Mediated Drug-Drug Interactions. // Drug Metabolism and Pharmacokinetics. – 2026. – DOI: 10.1016/j.dmpk.2026.101559. – URL: https://doi.org/10.1016/j.dmpk.2026.101559
Marina Naoi, Ryo Tamura, Masanobu Sato, Ikumi Tamai, & Yoshiyuki Shirasaka (2026). Impact of Membrane Permeability of P-glycoprotein Inhibitors on the Risk Assessment of Intestinal P-glycoprotein-Mediated Drug-Drug Interactions. Drug Metabolism and Pharmacokinetics. https://doi.org/10.1016/j.dmpk.2026.101559
Marina Naoi, et al. “Impact of Membrane Permeability of P-glycoprotein Inhibitors on the Risk Assessment of Intestinal P-glycoprotein-Mediated Drug-Drug Interactions.” Drug Metabolism and Pharmacokinetics, 2026. doi:10.1016/j.dmpk.2026.101559.
@article{Naoi2026,
title = {Impact of Membrane Permeability of P-glycoprotein Inhibitors on the Risk Assessment of Intestinal P-glycoprotein-Mediated Drug-Drug Interactions},
author = {Naoi, Marina and Tamura, Ryo and Sato, Masanobu and Tamai, Ikumi and Shirasaka, Yoshiyuki},
journal = {Drug Metabolism and Pharmacokinetics},
year = {2026},
doi = {10.1016/j.dmpk.2026.101559},
url = {https://doi.org/10.1016/j.dmpk.2026.101559}
}